Related Experiment Video
Updated: Feb 3, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the
Jennetta W Hammond1, Wen Q Qiu1, Daniel F Marker1
1Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, New York.
Abstract:
Microglial activation, increased proinflammatory cytokine production, and a reduction in synaptic density are key pathological features associated with HIV-associated neurocognitive disorders (HAND). Even with combination antiretroviral therapy (cART), more than 50% of HIV-positive individuals experience some type of cognitive impairment. Although viral replication is inhibited by cART, HIV proteins such as Tat are still produced within the nervous system that are neurotoxic, involved in synapse elimination, and provoke enduring neuroinflammation. As complement deposition on synapses followed by microglial engulfment has been shown during normal development and disease to be a mechanism for pruning synapses, we have tested whether complement is required for the loss of synapses that occurs after a cortical Tat injection mouse model of HAND. In Tat-injected animals evaluated 7 or 28 days after injection, levels of early complement pathway components, C1q and C3, are significantly elevated and associated with microgliosis and a loss of synapses. However, C1qa knockout mice have the same level of Tat-induced synapse loss as wild-type (WT) mice, showing that the C1q-initiated classical complement cascade is not driving synapse removal during HIV1 Tat-induced neuroinflammation.
Insights
The complement system, specifically C1q, does not drive synapse loss in a mouse model of HIV-associated neurocognitive disorders (HAND). This finding challenges the role of the classical complement cascade in Tat-induced neuroinflammation and synaptic pruning.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- HIV-associated neurocognitive disorders (HAND) involve microglial activation, inflammation, and synaptic loss, persisting even with combination antiretroviral therapy (cART).
- HIV Tat protein contributes to neurotoxicity, synapse elimination, and persistent neuroinflammation, independent of viral replication.
- Complement-mediated synapse elimination is a known mechanism in development and disease, prompting investigation into its role in HAND.
Purpose of the Study:
- To investigate whether the complement system is required for synapse loss in a mouse model of HAND induced by cortical Tat injection.
- To determine if the early complement pathway components C1q and C3 are involved in Tat-induced synaptic pruning.
Main Methods:
- Cortical Tat injection in wild-type (WT) and C1qa knockout (KO) mice.
- Assessment of synapse density, microgliosis, and complement component levels (C1q, C3) at 7 and 28 days post-injection.
Main Results:
- Tat injection led to elevated C1q and C3 levels, microgliosis, and significant synapse loss in WT mice.
- C1qa knockout mice exhibited comparable levels of Tat-induced synapse loss to WT mice.
- The C1q-initiated classical complement cascade was not the driving mechanism for synapse removal in this HAND model.
Conclusions:
- The classical complement cascade, initiated by C1q, is not essential for Tat-induced synapse loss in the studied mouse model.
- These findings suggest alternative pathways mediate synapse elimination during HIV Tat-induced neuroinflammation.
- Further research is needed to elucidate the precise mechanisms of synapse loss in HAND.
Related Concept Videos
The Synapse
Intracellular Signaling Cascades
Rab Cascades
Classical Conditioning
Ivan Pavlov observed that dogs...
Complement System
Intrinsically Disordered Proteins

